XML 45 R29.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT INFORMATION (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Company’s Segment Information | The Company’s reportable segment information was as follows:
|  | Three Months Ended September 30, |
(in millions) |  | 2025 |  |  |
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total |  |  |
Net sales |  | $ | 259 |  |  | $ | 357 |  |  | $ | 205 |  |  | $ | 83 |  |  | $ | 904 |  |  |  |
Adjusted cost of products sold (a) |  | 157 |  |  | 140 |  |  | 95 |  |  | 33 |  |  |  |  |  |
Adjusted selling expenses (b) |  | 55 |  |  | 77 |  |  | 56 |  |  | 13 |  |  |  |  |  |
Adjusted G&A expenses (b) |  | 20 |  |  | 18 |  |  | 20 |  |  | 7 |  |  |  |  |  |
Adjusted R&D expenses (c) |  | 17 |  |  | 6 |  |  | 12 |  |  | 2 |  |  |  |  |  |
Segment adjusted operating income |  | $ | 10 |  |  | $ | 116 |  |  | $ | 22 |  |  | $ | 28 |  |  | $ | 176 |  |  |  |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 69 |  |  |  |
Interest expense, net |  |  |  |  |  |  |  |  |  | 23 |  |  |  |
Other income |  |  |  |  |  |  |  |  |  | (11) |  |  |  |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 262 |  |  |  |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 5 |  |  |  |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 57 |  |  |  |
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations |  |  |  |  |  |  |  |  |  | 1 |  |  |  |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (230) |  |  |  |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
|  | Three Months Ended September 30,
(in millions) |  | 2024
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total
Net sales |  | $ | 269 |  |  | $ | 369 |  |  | $ | 241 |  |  | $ | 72 |  |  | $ | 951 |
Adjusted cost of products sold (a) |  | 156 |  |  | 138 |  |  | 100 |  |  | 25 |  |  |
Adjusted selling expenses (b) |  | 60 |  |  | 76 |  |  | 75 |  |  | 12 |  |  |
Adjusted G&A expenses (b) |  | 19 |  |  | 17 |  |  | 29 |  |  | 7 |  |  |
Adjusted R&D expenses (c) |  | 18 |  |  | 6 |  |  | 13 |  |  | 2 |  |  |
Segment adjusted operating income |  | $ | 16 |  |  | $ | 132 |  |  | $ | 24 |  |  | $ | 26 |  |  | $ | 198 |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 79 |
Interest expense, net |  |  |  |  |  |  |  |  |  | 18 |
Other income |  |  |  |  |  |  |  |  |  | (2) |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 504 |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 23 |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 54 |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (478) |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
|  | Nine Months Ended September 30, |
(in millions) |  | 2025 |  |  |
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total |  |  |
Net sales |  | $ | 737 |  |  | $ | 1,097 |  |  | $ | 648 |  |  | $ | 237 |  |  | $ | 2,719 |  |  |  |
Adjusted cost of products sold (a) |  | 432 |  |  | 402 |  |  | 286 |  |  | 93 |  |  |  |  |  |
Adjusted selling expenses (b) |  | 167 |  |  | 220 |  |  | 164 |  |  | 39 |  |  |  |  |  |
Adjusted G&A expenses (b) |  | 58 |  |  | 55 |  |  | 59 |  |  | 20 |  |  |  |  |  |
Adjusted R&D expenses (c) |  | 51 |  |  | 17 |  |  | 35 |  |  | 7 |  |  |  |  |  |
Segment adjusted operating income |  | $ | 29 |  |  | $ | 403 |  |  | $ | 104 |  |  | $ | 78 |  |  | $ | 614 |  |  |  |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 224 |  |  |  |
Interest expense, net |  |  |  |  |  |  |  |  |  | 66 |  |  |  |
Other income |  |  |  |  |  |  |  |  |  | (10) |  |  |  |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 497 |  |  |  |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 18 |  |  |  |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 156 |  |  |  |
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations |  |  |  |  |  |  |  |  |  | 2 |  |  |  |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (339) |  |  |  |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
|  | Nine Months Ended September 30,
(in millions) |  | 2024
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total
Net sales |  | $ | 769 |  |  | $ | 1,108 |  |  | $ | 788 |  |  | $ | 223 |  |  | $ | 2,888 |
Adjusted cost of products sold (a) |  | 452 |  |  | 424 |  |  | 307 |  |  | 83 |  |  |
Adjusted selling expenses (b) |  | 183 |  |  | 239 |  |  | 238 |  |  | 39 |  |  |
Adjusted G&A expenses (b) |  | 57 |  |  | 56 |  |  | 96 |  |  | 21 |  |  |
Adjusted R&D expenses (c) |  | 56 |  |  | 17 |  |  | 39 |  |  | 7 |  |  |
Segment adjusted operating income |  | $ | 21 |  |  | $ | 372 |  |  | $ | 108 |  |  | $ | 73 |  |  | $ | 574 |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 227 |
Interest expense, net |  |  |  |  |  |  |  |  |  | 53 |
Other income |  |  |  |  |  |  |  |  |  | (10) |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 510 |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 45 |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 162 |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (413) |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
Depreciation and Amortization
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(in millions) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Connected Technology Solutions |  | 48 |  | 44 |  |  | 137 |  | 130
Essential Dental Solutions |  | 9 |  | 9 |  |  | 26 |  | 26
Orthodontic and Implant Solutions |  | 24 |  | 25 |  |  | 66 |  | 75
Wellspect Healthcare |  | 5 |  | 5 |  |  | 13 |  | 14
All other (a) |  | 6 |  | 6 |  |  | 17 |  | 16
Total |  | 92 |  | 89 |  |  | 259 |  | 261
(a) Includes unallocated corporate costs for depreciation and amortization. The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows:
(in millions) |  | December 31, 2024 |  | Provisions |  | Amounts Applied |  | Change in Estimates |  | September 30, 2025
Connected Technology Solutions |  | $ | 9 |  |  | $ | 4 |  |  | $ | (9) |  |  | $ | (2) |  |  | $ | 2 |
Essential Dental Solutions |  | 11 |  |  | 1 |  |  | (9) |  |  | (1) |  |  | 2 |
Orthodontic and Implant Solutions |  | 9 |  |  | 5 |  |  | (8) |  |  | — |  |  | 6 |
Wellspect Healthcare |  | 3 |  |  | 1 |  |  | (2) |  |  | — |  |  | 2 |
All Other |  | 1 |  |  | 8 |  |  | (7) |  |  | — |  |  | 2 |
Total |  | $ | 33 |  |  | $ | 19 |  |  | $ | (35) |  |  | $ | (3) |  |  | $ | 14 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration